PROSTIGMINE 0.5 mg/1 ml, solution for injection 6 ampoules of 1 ml
Active ingredients: Neostigmine methylsulfate
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection6 ampoules of 1 mlintramusculaire;intraveineuse;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROSTIGMINE 0,5 mg/1 ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse;sous-cutanée
- Presentation description
- 6 ampoule(s) en verre de 1 ml
- Marketing authorisation holder
- VIATRIS MEDICAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1932
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61601542CIP73087036CIP133400930870365Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NÉOSTIGMINE (MÉTILSULFATE DE)solution | 0,5 mg · une ampoule de 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.